Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hawkins

Showing results (551-560 of 570) with videos related to

Pageof 57
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2021
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F Shern, Joanna Selfe, Elisa Izquierdo, et al.
Journal of the National Cancer Institute|August 12, 2025
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adultsJoseph Flores-Toro, Subhashini Jagu, Malcolm Smith, et al.
Pediatric Blood & Cancer|June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goalsMarielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug AdministrationAndrew Dj Pearson, Susan Chi, Theodore W Laetscht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric CancerJoseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2018
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008Jeremy Whelan, Marie-Cecile Le Deley, Uta Dirksen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancerAndrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
The Lancet. Oncology|July 24, 2020
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trialAaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008Uta Dirksen, Bernadette Brennan, Marie-Cécile Le Deley, et al.
Pageof 57

Showing results (551-560 of 570) with videos related to

Sort By:
Pageof 57
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2021
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F Shern, Joanna Selfe, Elisa Izquierdo, et al.
Journal of the National Cancer Institute|August 12, 2025
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adultsJoseph Flores-Toro, Subhashini Jagu, Malcolm Smith, et al.
Pediatric Blood & Cancer|June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goalsMarielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug AdministrationAndrew Dj Pearson, Susan Chi, Theodore W Laetscht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric CancerJoseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2018
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008Jeremy Whelan, Marie-Cecile Le Deley, Uta Dirksen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancerAndrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
The Lancet. Oncology|July 24, 2020
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trialAaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008Uta Dirksen, Bernadette Brennan, Marie-Cécile Le Deley, et al.
Pageof 57